You are here

  • Home
  • Archive
  • Volume 14, Issue 4
  • Rofecoxib increased risk of CV events in patients with history of colorectal adenomas ⩾1 year after stopping treatmentRofecoxib increased risk of CV events in patients with history of colorectal adenomas ⩾1 year after stopping treatment

Article info

Article menu
Download PDFPDF
Therapeutics
Rofecoxib increased risk of CV events in patients with history of colorectal adenomas ⩾1 year after stopping treatment

Authors

View Full Text

Citation

Chan FKL
Rofecoxib increased risk of CV events in patients with history of colorectal adenomas ⩾1 year after stopping treatment
BMJ Evidence-Based Medicine 2009;14:111.

Publication history

  • First published July 31, 2009.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2009 by the BMJ Publishing Group Ltd for Evidence-Based Medicine and by the ACP for portions reproduced from ACP Journal Club